Literature DB >> 10429246

Evolution of a cytokine using DNA family shuffling.

C C Chang1, T T Chen, B W Cox, G N Dawes, W P Stemmer, J Punnonen, P A Patten.   

Abstract

DNA shuffling of a family of over 20 human interferon-alpha (Hu-IFN-alpha) genes was used to derive variants with increased antiviral and antiproliferation activities in murine cells. A clone with 135,000-fold improved specific activity over Hu-IFN-alpha2a was obtained in the first cycle of shuffling. After a second cycle of selective shuffling, the most active clone was improved 285,000-fold relative to Hu-IFN-alpha2a and 185-fold relative to Hu-IFN-alpha1. Remarkably, the three most active clones were more active than the native murine IFN-alphas. These chimeras are derived from up to five parental genes but contained no random point mutations. These results demonstrate that diverse cytokine gene families can be used as starting material to rapidly evolve cytokines that are more active, or have superior selectivity profiles, than native cytokine genes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10429246     DOI: 10.1038/11737

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  26 in total

1.  Prospecting metagenomic enzyme subfamily genes for DNA family shuffling by a novel PCR-based approach.

Authors:  Qiuyan Wang; Huili Wu; Anming Wang; Pengfei Du; Xiaolin Pei; Haifeng Li; Xiaopu Yin; Lifeng Huang; Xiaolong Xiong
Journal:  J Biol Chem       Date:  2010-10-20       Impact factor: 5.157

Review 2.  Laboratory-directed protein evolution.

Authors:  Ling Yuan; Itzhak Kurek; James English; Robert Keenan
Journal:  Microbiol Mol Biol Rev       Date:  2005-09       Impact factor: 11.056

3.  Effects of recombination on complex regulatory circuits.

Authors:  Olivier C Martin; Andreas Wagner
Journal:  Genetics       Date:  2009-08-03       Impact factor: 4.562

4.  Constraint and Contingency Pervade the Emergence of Novel Phenotypes in Complex Metabolic Systems.

Authors:  Sayed-Rzgar Hosseini; Andreas Wagner
Journal:  Biophys J       Date:  2017-08-08       Impact factor: 4.033

5.  Phenotypic innovation through recombination in genome-scale metabolic networks.

Authors:  Sayed-Rzgar Hosseini; Olivier C Martin; Andreas Wagner
Journal:  Proc Biol Sci       Date:  2016-09-28       Impact factor: 5.349

6.  DNA family shuffling of hyperthermostable beta-glycosidases.

Authors:  Thijs Kaper; Stan J J Brouns; Ans C M Geerling; Willem M De Vos; John Van der Oost
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

7.  Attenuation of porcine reproductive and respiratory syndrome virus by molecular breeding of virus envelope genes from genetically divergent strains.

Authors:  Yan-Yan Ni; Tanja Opriessnig; Lei Zhou; Dianjun Cao; Yao-Wei Huang; Patrick G Halbur; Xiang-Jin Meng
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

8.  Directed evolution of gene-shuffled IFN-alpha molecules with activity profiles tailored for treatment of chronic viral diseases.

Authors:  Amy D Brideau-Andersen; Xiaojian Huang; Siu-Chi Chang Sun; Teddy T Chen; Diane Stark; Ian J Sas; Linda Zadik; Glenn N Dawes; Douglas R Guptill; Robert McCord; Sridhar Govindarajan; Ajoy Roy; Shumin Yang; Judy Gao; Yong Hong Chen; Niels Jørgen Ø Skartved; Annette K Pedersen; David Lin; Christopher P Locher; Indrani Rebbapragada; Anne Dam Jensen; Steven H Bass; Torben L Straight Nissen; Sridhar Viswanathan; Graham R Foster; Julian A Symons; Phillip A Patten
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-09       Impact factor: 11.205

9.  Construction of chimeric catechol 2,3-dioxygenase exhibiting improved activity against the suicide inhibitor 4-methylcatechol.

Authors:  Akiko Okuta; Kouhei Ohnishi; Shigeaki Harayama
Journal:  Appl Environ Microbiol       Date:  2004-03       Impact factor: 4.792

Review 10.  New therapies for chronic hepatitis C virus infection.

Authors:  Anouk Dev; Keyur Patel; John G McHutchison
Journal:  Curr Gastroenterol Rep       Date:  2004-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.